Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,652 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conventional heart failure therapy in cardiac ATTR amyloidosis.
Ioannou A, Massa P, Patel RK, Razvi Y, Porcari A, Rauf MU, Jiang A, Cabras G, Filisetti S, Bolhuis RE, Bandera F, Venneri L, Martinez-Naharro A, Law S, Kotecha T, Virsinskaite R, Knight DS, Emdin M, Petrie A, Lachmann H, Wechelakar A, Petrie M, Hughes A, Freemantle N, Hawkins PN, Whelan C, McMurray JJV, Gillmore JD, Fontana M. Ioannou A, et al. Among authors: law s. Eur Heart J. 2023 Aug 14;44(31):2893-2907. doi: 10.1093/eurheartj/ehad347. Eur Heart J. 2023. PMID: 37216684 Free PMC article.
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Cohen OC, Brodermann MH, Blakeney IJ, Mahmood S, Sachchithanantham S, Ravichandran S, Law S, Lachmann HJ, Whelan CJ, Popat R, Rabin N, Yong K, Kyriakou C, Shah R, Cheesman S, Worthington S, Hawkins P, Gillmore JD, Wechalekar AD. Cohen OC, et al. Among authors: law s. Amyloid. 2020 Sep;27(3):200-205. doi: 10.1080/13506129.2020.1765768. Epub 2020 May 15. Amyloid. 2020. PMID: 32408823 Clinical Trial.
The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis.
Cohen OC, Law S, Lachmann HJ, Sharpley F, Ravichandran S, Mahmood S, Sachchithanantham S, Whelan CJ, De Azcona Naharro AM, Fontana M, Hawkins PN, Gillmore JD, Wechalekar AD. Cohen OC, et al. Among authors: law s. Blood Cancer J. 2020 May 22;10(5):60. doi: 10.1038/s41408-020-0325-2. Blood Cancer J. 2020. PMID: 32444621 Free PMC article. No abstract available.
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
Law S, Petrie A, Chacko L, Cohen OC, Ravichandran S, Gilbertson JA, Rowczenio D, Wechalekar A, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Fontana M, Gillmore JD. Law S, et al. ESC Heart Fail. 2020 Dec;7(6):3942-3949. doi: 10.1002/ehf2.12989. Epub 2020 Sep 13. ESC Heart Fail. 2020. PMID: 32924285 Free PMC article.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Renal transplant outcomes in amyloidosis.
Law S, Cohen O, Lachmann HJ, Rezk T, Gilbertson JA, Rowczenio D, Wechalekar AD, Hawkins PN, Motallebzadeh R, Gillmore JD. Law S, et al. Nephrol Dial Transplant. 2021 Jan 25;36(2):355-365. doi: 10.1093/ndt/gfaa293. Nephrol Dial Transplant. 2021. PMID: 33439995
Cardiac Magnetic Resonance-Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid.
Chacko L, Boldrini M, Martone R, Law S, Martinez-Naharrro A, Hutt DF, Kotecha T, Patel RK, Razvi Y, Rezk T, Cohen OC, Brown JT, Srikantharajah M, Ganesananthan S, Lane T, Lachmann HJ, Wechalekar AD, Sachchithanantham S, Mahmood S, Whelan CJ, Knight DS, Moon JC, Kellman P, Gillmore JD, Hawkins PN, Fontana M. Chacko L, et al. Among authors: law s. Circ Cardiovasc Imaging. 2021 Apr 20:CIRCIMAGING121012506. doi: 10.1161/CIRCIMAGING.121.012506. Online ahead of print. Circ Cardiovasc Imaging. 2021. PMID: 33876651
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy.
Law S, Petrie A, Chacko L, Cohen OC, Ravichandran S, Gilbertson JA, Rowczenio D, Wechalekar AD, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Fontana M, Gillmore JD. Law S, et al. Heart. 2022 Mar;108(6):474-478. doi: 10.1136/heartjnl-2021-319063. Epub 2021 May 14. Heart. 2022. PMID: 33990410 Free PMC article.
1,652 results